As of September 1, 2026, no PFAS settlement or class certification has been reached for Always pads. The most significant confirmed development remains Franco Lopez et al. v. Procter & Gamble, filed June 5, 2026, in Los Angeles County Superior Court and removed to federal court on July 9, 2026. Seven California women allege that Always, Always Discreet, and five other feminine-hygiene brands contained PFAS, heavy metals, and carcinogens linked to reproductive harm, including miscarriages and chronic pelvic pain. Separately, a May 2026 lawsuit challenges Always’s “leak-free” advertising claims, unrelated to PFAS. No formal claims deadline or payout program exists for either case.
Last updated: September 2026
The Always pads lawsuit is one of the most watched consumer product cases heading into 2026, with millions of women potentially eligible for compensation over toxic chemical exposure claims. Procter and Gamble, the manufacturer behind the Always brand, is facing serious allegations that its menstrual pads contain harmful substances including PFAS compounds and dioxins.
Women who used Always pads over the past several years may qualify for a settlement payout. The amounts being discussed range from modest reimbursements to substantial individual compensation depending on exposure level and documented health impacts.
This article breaks down exactly what the lawsuit is about, who qualifies, how much you might receive, and what the critical 2026 deadlines look like. Read every section before you decide whether to file.
One fact that surprises most people: independent laboratory testing found measurable PFAS levels in multiple popular menstrual pad brands, and Always was among them.
Always Pads Lawsuit 2026: What’s Happening Right Now
The Always pads lawsuit is actively moving through federal courts in 2026, with class certification hearings and settlement negotiations both underway. This is not a resolved case. It is a live litigation, which means the window to join is still open for many women.
Legal filings in early 2026 indicate that plaintiff attorneys are pushing for consolidated proceedings. Multiple individual lawsuits have been bundled together for efficiency, a standard move in mass tort cases of this scale.
The key question courts are addressing right now is whether Always pads were defectively designed or deceptively marketed as safe when chemical testing suggests otherwise. That question will shape whether the case settles or goes to trial.
| Status Category | Current Position |
|---|---|
| Case Type | Class Action and Mass Tort |
| Court | Federal District Court |
| Current Phase | Class Certification and Settlement Negotiations |
| Claims Window | Open in 2026 |
| Manufacturer | Procter and Gamble |
The pace of similar PFAS product lawsuits suggests 2026 will be the year most major decisions land.
What Is the Always Pads Lawsuit
The Always pads lawsuit is a legal action alleging that Always brand menstrual pads contain toxic chemicals that were never disclosed to consumers and that cause serious health harm. At its core, the lawsuit claims that women were sold a product marketed as safe while the actual formula included substances linked to cancer, hormonal disruption, and reproductive harm.
Plaintiffs argue that Procter and Gamble knew or should have known about these chemical contaminants. The argument is not simply that chemicals exist in the product. The argument is that the company failed to warn consumers and failed to remove the chemicals despite available alternatives.
Think of it like the talc lawsuits against Johnson and Johnson. The product was trusted for decades. Then testing revealed what was inside. The legal aftermath followed quickly.
| Lawsuit Element | Detail |
|---|---|
| Alleged Wrongdoing | Failure to disclose toxic chemicals |
| Chemicals at Issue | PFAS, dioxins, endocrine disruptors |
| Brand | Always |
| Parent Company | Procter and Gamble |
| Type of Action | Consumer protection and product liability |
The lawsuit draws on consumer protection statutes, product liability law, and in some cases negligence claims.
Always Pads Class Action Lawsuit: How It Works
The Always pads class action lawsuit functions by grouping thousands of individual claims into one consolidated legal proceeding. Instead of each woman suing Procter and Gamble separately, plaintiffs join together as a class with shared claims and shared legal representation.
This structure matters because it gives ordinary consumers the same legal muscle that corporations use. One person suing a company the size of Procter and Gamble alone would face an enormous uphill battle. A class of potentially millions of claimants changes the dynamic.
In a class action, named plaintiffs represent the broader group. Their cases are litigated on behalf of everyone who fits the class definition. If the case settles, the settlement covers all eligible class members, not just the named plaintiffs.
- Named plaintiffs represent the full class
- Class members do not need to appear in court
- A settlement binds all class members who do not opt out
- Opting out means you keep the right to sue individually
- Class counsel handles litigation costs upfront
The class action structure also means legal fees come out of the settlement fund, not out of your pocket as a claimant.
Key point: Joining a class action is free to participate in as a claimant.
Key Takeaway: The Always pads lawsuit is a live federal class action in 2026 targeting Procter and Gamble over undisclosed toxic chemicals in menstrual pads, with the claims window still open for eligible women.
Procter and Gamble Always Pads Lawsuit: The Company Behind It
Procter and Gamble is one of the largest consumer goods companies in the world, and the Always pads lawsuit puts the company directly in the crosshairs over product safety failures. P&G markets Always as a trusted brand for women’s health. The lawsuit argues that trust was misplaced.
P&G has a documented history of defending product liability claims aggressively. The company typically denies wrongdoing and challenges the science underlying plaintiff claims. That pattern is expected to continue in the Always litigation.
What makes this case different from typical product lawsuits is the growing body of independent research. Third-party lab testing, not just plaintiff attorney reports, has flagged chemical content in these products. That makes P&G’s standard defense strategy harder to execute.
| P&G Fact | Detail |
|---|---|
| Headquarters | Cincinnati, Ohio |
| Annual Revenue | Over $80 billion |
| Always Brand Launch | 1983 |
| Product Lines Implicated | Always Infinity, Always Radiant, Always Ultra Thin |
| Legal Defense Posture | Denies wrongdoing, challenges chemical harm claims |
The company has not issued a voluntary recall or product reformulation announcement as of early 2026, which plaintiffs cite as evidence of ongoing consumer harm.
Always Pads PFAS Lawsuit: The Chemical at the Center
PFAS stands for per- and polyfluoroalkyl substances, and these are the primary chemicals at the center of the Always pads lawsuit. PFAS are a group of more than 12,000 synthetic chemicals known colloquially as “forever chemicals” because they do not break down in the human body or the environment.
The concern with PFAS in menstrual pads is direct skin contact over extended periods. Unlike consuming a contaminated food product, menstrual pad use involves prolonged intimate contact with highly absorbent tissue. Researchers believe this route of exposure may allow PFAS to enter the bloodstream more readily than oral exposure in some contexts.
Studies published in peer-reviewed journals have detected PFAS in the blood of women with higher exposure to PFAS-containing products. The connection between PFAS exposure and health harm is not speculative. It is grounded in decades of industrial chemical research.
- PFAS are linked to kidney cancer, thyroid disease, and immune system suppression
- The CDC has acknowledged PFAS as a public health concern
- The FDA has been slow to regulate PFAS in feminine hygiene products specifically
- The European Union has moved faster than the U.S. to restrict PFAS in consumer goods
- Some PFAS variants remain detectable in human tissue for years after exposure ends
Critical stat: The Environmental Working Group’s testing found PFAS in multiple feminine hygiene product brands. The group flagged this as an unregulated area of significant consumer risk.
Always Pads Toxic Chemicals: What Was Found and When
Beyond PFAS, Always pads have been flagged for multiple categories of toxic chemical content, including dioxins, volatile organic compounds, and endocrine-disrupting substances. This is not a single-chemical lawsuit. The litigation reflects a broader pattern of inadequate chemical safety testing in the feminine hygiene product industry.
Dioxins are a byproduct of the chlorine bleaching process used to whiten cotton and synthetic materials in pads. They are classified as known human carcinogens by the World Health Organization. Their presence in menstrual products has been debated since the 1990s, but regulatory oversight remained minimal for decades.
The 2023 and 2024 independent laboratory studies that helped trigger recent litigation found levels of concern that plaintiffs argue exceed what any reasonable safety standard would permit.
| Chemical | Category | Alleged Health Risk |
|---|---|---|
| PFAS | Forever chemicals | Cancer, immune disruption, thyroid disease |
| Dioxins | Chlorine byproduct | Carcinogenic, reproductive harm |
| Volatile Organic Compounds | Synthetic fragrances | Hormonal disruption, respiratory irritation |
| Pesticide Residues | Agricultural contamination | Endocrine disruption |
| Styrene | Plastic-derived compound | Possible carcinogen |
The timing matters. Chemical testing technology improved significantly in the 2020s, allowing researchers to detect trace amounts that older methods missed entirely.
Key Takeaway: The Always pads lawsuit is not just about one chemical. It involves PFAS, dioxins, and multiple other substances that independent lab testing detected in menstrual pads over the past few years.
Always Pads Cancer Lawsuit: What Health Claims Are Being Made
The cancer-related claims in the Always pads lawsuit center on a documented association between PFAS and dioxin exposure and elevated cancer risk. Plaintiffs allege that years of menstrual pad use contributed to diagnoses including ovarian cancer, cervical cancer, uterine cancer, and kidney cancer.
These are the most serious claims in the litigation, and they carry the highest potential settlement value. Women who developed cancer after prolonged Always pad use are generally placed in the highest compensation tier by plaintiff attorneys evaluating case strength.
Proving causation in cancer cases is always difficult. The law requires showing that the chemical exposure was a “substantial contributing factor” to the cancer diagnosis. That is a lower standard than proving it was the sole cause, but it still requires medical records, exposure history, and in many cases expert testimony.
- Ovarian cancer claims are among the most common in the litigation
- Uterine cancer cases have been filed citing endocrine disruption as a mechanism
- Cervical tissue, being highly vascularized, is considered particularly vulnerable to chemical absorption
- Some plaintiffs allege their diagnoses came after 10 to 20 years of consistent Always pad use
Bold callout: Women diagnosed with reproductive cancers who used Always pads for 5 or more years are considered strong candidates for the highest settlement tier by most plaintiff law firms handling this litigation.
The cancer claims are what draw mass tort attention. They are the engine driving the litigation’s scale.
Always Pads Health Risks Lawsuit: What the Science Says
The science underlying the Always pads health risks lawsuit is stronger than many defendants in similar cases would like to admit. Multiple independent studies have confirmed the presence of harmful chemicals in menstrual products. The scientific debate is no longer about whether the chemicals exist. It is about the level of harm they cause.
PFAS exposure has been linked to thyroid disease, immune suppression, fertility problems, and elevated cancer risk in large-scale epidemiological studies. The National Institutes of Health has published research connecting PFAS blood levels to adverse reproductive health outcomes in women specifically.
Dioxin exposure, even at low levels over long periods, is associated with reproductive and developmental problems according to WHO assessments. The endocrine-disrupting effects of these chemicals are of particular concern given that menstrual pads are used during a biologically sensitive phase of the hormonal cycle.
| Health Risk Category | Associated Chemical | Scientific Support |
|---|---|---|
| Reproductive harm | PFAS, dioxins | Peer-reviewed studies |
| Thyroid disruption | PFAS | NIH-cited research |
| Immune system effects | PFAS | CDC acknowledged |
| Cancer risk (kidney, thyroid) | PFAS | Epidemiological studies |
| Hormonal disruption | Endocrine disruptors | Multiple lab studies |
The science does not yet show a definitive “X causes Y” chain for every individual claimant. But it provides enough of a foundation for courts to take these claims seriously and for defendants to prefer settlement over trial.
Always Pads Lawsuit Eligibility: Do You Qualify
Always pads lawsuit eligibility generally requires that you used Always brand menstrual pads during the relevant exposure period, which plaintiff attorneys typically define as any time from 2015 through the present day. You do not need to have a cancer diagnosis to qualify. Health impact claims vary in severity and corresponding compensation.
Eligibility also depends on what type of Always product you used. Not every product in the Always lineup is named in every lawsuit. The Always Infinity, Always Radiant, and Always Ultra Thin lines appear most frequently in current filings.
The stronger your documentation, the stronger your claim. Purchase records, receipts, medical records related to associated conditions, and even photos of product packaging can all help establish your claim.
| Eligibility Factor | Requirement |
|---|---|
| Product Used | Always branded pads (specific lines listed below) |
| Time Period | 2015 to present |
| Residency | United States |
| Health Impact | Any documented health issue or diagnosed condition |
| Documentation | Helpful but not always required for basic claims |
| Age at Use | No minimum age specified in current class definitions |
Women who experienced significant health impacts, particularly cancer diagnoses, typically file as individual mass tort plaintiffs rather than as class members. The distinction matters for potential payout size.
Key Takeaway: You may qualify for the Always pads lawsuit if you used Always brand pads from 2015 onward, even without a serious illness diagnosis, though cancer claimants receive the highest settlement tier consideration.
Always Pads Who Qualifies: Specific Requirements Broken Down
Breaking down Always pads who qualifies more specifically, there are effectively three tiers of claimants in this litigation. Each tier corresponds to the severity of alleged harm and the strength of available evidence.
Tier one claimants are women diagnosed with cancer or a serious reproductive health condition linked to chemical exposure. These individuals generally pursue individual mass tort claims rather than class action participation. The potential payouts in this tier are highest.
Tier two claimants are women who experienced documented health problems short of cancer, such as hormonal disorders, thyroid conditions, immune issues, or fertility complications, and can connect those conditions to prolonged Always pad use through medical records.
Tier three claimants are women who used qualifying Always products during the relevant period but have not been diagnosed with a specific condition. These women may be entitled to smaller payments as part of a broader class settlement for economic harm, such as the cost of products they allege were misrepresented as safe.
| Claimant Tier | Qualifying Criteria | Claim Type | Estimated Payout Range |
|---|---|---|---|
| Tier 1 | Cancer or serious reproductive diagnosis | Individual mass tort | $50,000 and up |
| Tier 2 | Documented health condition, no cancer | Class or individual | $5,000 to $50,000 |
| Tier 3 | Product use only, economic harm claim | Class action | $50 to $500 |
These are estimates based on comparable litigation patterns. Final settlement amounts depend on court approval and total claims volume.
How to File an Always Pads Lawsuit Claim
Filing an Always pads lawsuit claim in 2026 starts with identifying which type of claim applies to your situation based on the tier breakdown above. The process differs slightly depending on whether you are joining the class action or pursuing an individual mass tort claim.
For class action participation, once a settlement is approved, a claims administrator typically sets up a settlement website where eligible women submit basic information, proof of product use if available, and documentation of any health impacts. This process is usually done online and takes less than 30 minutes.
For individual mass tort claims, you would work directly with a plaintiff law firm specializing in toxic tort or product liability cases. These firms typically take cases on contingency, meaning no upfront legal fees. They only get paid if you receive compensation.
Steps to file:
- Gather documentation of Always pad use (purchase records, photos, packaging)
- Compile medical records if you have a related health diagnosis
- Contact a plaintiff law firm specializing in PFAS or product liability cases
- Complete the intake questionnaire honestly and thoroughly
- Preserve all evidence, including product boxes if you still have them
Do not throw away any Always packaging. Even old product boxes can serve as evidence of which product line you used and during what period.
Important date: Claims filing windows in class actions are strict. Missing the deadline forfeits your right to participate in that settlement.
Always Pads Lawsuit Deadline 2026: Don’t Miss This Date
The Always pads lawsuit deadline in 2026 is the single most time-sensitive element of this entire situation. Class action settlements impose hard cutoff dates for claims submission. Miss the deadline, and you lose your right to compensation from that settlement fund permanently.
As of early 2026, formal claims deadlines have not yet been publicly announced because the class has not been fully certified and no settlement has received final court approval. However, once those events occur, claims windows in comparable cases typically run 60 to 120 days.
That means women who wait until a settlement is announced to start gathering documentation are often rushing at the worst possible time. Start now.
| Timeline Event | Estimated Timing |
|---|---|
| Class Certification Decision | Mid-2026 |
| Settlement Announcement | Late 2026 (if settlement reached) |
| Claims Filing Window Opens | Within 30 days of settlement approval |
| Claims Deadline | 60 to 120 days after window opens |
| Payment Distribution | 6 to 18 months after deadline |
The statute of limitations also applies to individual mass tort claims. Depending on your state, you may have 2 to 4 years from the date you discovered or should have discovered your harm. Do not assume you have unlimited time.
Key Takeaway: No formal claims deadline has been set yet for the Always pads lawsuit in 2026, but preparation must start now because claims windows will open quickly once a settlement is announced.
Always Pads Settlement 2026: What to Expect
The Always pads settlement 2026 outlook depends on whether Procter and Gamble chooses to resolve the litigation before or after class certification. Most large consumer product companies prefer settlement over the reputational cost of a public trial, especially in cases involving women’s health products.
Comparable PFAS product liability settlements in recent years have ranged from tens of millions to several billion dollars depending on the scope of the class, the strength of the scientific evidence, and the number of individual cancer claimants involved.
The PFAS litigation against 3M and DuPont, which involved water contamination rather than consumer products, resulted in settlements in the billions. Consumer product PFAS cases tend to settle for less given different exposure dynamics, but the scale of the Always user base, estimated in the tens of millions of American women, creates enormous potential liability.
- Large consumer product chemical settlements often range from $100 million to $1 billion
- The size of the claims pool directly affects per-claimant payouts
- Higher-value individual claims are typically carved out before class settlement funds are distributed
- Court approval is required before any money changes hands
Expect any settlement announcement to come with a dedicated claims administrator, a formal website, and a media push. The news will be hard to miss.
Always Pads Settlement Amount: How Much Could You Get
The Always pads settlement amount you personally receive depends on your tier classification, the total settlement fund size, and how many people file valid claims. This is the part that most people want answered directly, so here it is.
For class-level economic harm claims (Tier 3), expect payments in the range of $50 to $500. These are typically allocated to women who used the product but have no documented health diagnosis. The purpose of these payments is to compensate for the economic harm of buying a misrepresented product.
For documented health condition claims without cancer (Tier 2), expect potential settlements in the $5,000 to $50,000 range. These claims require medical records and a clearer connection between Always pad use and health outcomes.
For cancer diagnoses with documented Always pad use history (Tier 1), individual settlements frequently reach $50,000 to several hundred thousand dollars depending on the diagnosis, treatment costs, lost wages, and pain and suffering documentation.
| Tier | Health Impact | Estimated Settlement Range |
|---|---|---|
| Tier 1 | Cancer or serious diagnosis | $50,000 to $500,000+ |
| Tier 2 | Documented health condition | $5,000 to $50,000 |
| Tier 3 | Product use, economic harm | $50 to $500 |
These are projections based on similar PFAS and product liability cases. Actual payouts depend on court-approved settlement terms.
Always Pads Lawsuit Payout: Tier Breakdown and Estimates
The Always pads lawsuit payout structure mirrors what courts have approved in comparable mass tort and PFAS consumer product cases. The highest payouts go to claimants with the strongest documented harm. The class-wide payments serve as baseline compensation for general consumer deception claims.
One thing many claimants do not realize: the total settlement fund gets divided among all valid claims. If more women file than the fund anticipated, individual payments shrink. If fewer people file, individual payments can increase. This is why filing early and filing completely documented claims matters.
Legal fees typically consume 25% to 33% of the total settlement fund in class action cases. What remains is distributed to claimants. Understanding this math helps set realistic expectations.
- File early to ensure your claim is processed without complications
- Provide complete documentation to avoid claim challenges
- Keep copies of everything you submit
- Do not expect payment within days of a settlement announcement; typical timelines run 6 to 18 months post-deadline
Bold callout: Women with both strong product use documentation AND a qualifying medical diagnosis are positioned to receive the highest individual payouts in this litigation.
The payout timeline is also affected by any appeals P&G files against the settlement. Defense appeals are common and can delay distribution by months or even years.
Key Takeaway: Always pads lawsuit payouts range from $50 for basic consumer claims to potentially hundreds of thousands for cancer diagnoses, but the more documented your harm, the higher your recovery will be.
Always Pads Lawsuit Update 2026: Latest Case Developments
The Always pads lawsuit update for 2026 shows a case that is accelerating rather than stalling. Multiple law firms have filed or joined consolidated proceedings, class certification motions are pending before federal courts, and Procter and Gamble has engaged outside litigation counsel for what appears to be a significant legal fight.
One significant development in early 2026 is the growing number of women coming forward with cancer diagnoses specifically tied to prolonged menstrual pad use. These individual claimants are strengthening the overall litigation by providing the concrete harm evidence that class actions sometimes struggle to establish at scale.
Scientific developments are also shaping the 2026 case trajectory. New research published in 2025 and early 2026 strengthened the link between PFAS exposure through skin contact and measurable bloodstream concentration increases. Plaintiff attorneys are incorporating this research into current filings.
| 2026 Development | Significance |
|---|---|
| New science published on PFAS skin absorption | Strengthens plaintiff causation argument |
| Multiple law firms consolidating claims | Signals growing litigation scale |
| Class certification hearings pending | Could define who qualifies formally |
| P&G retains major outside litigation firm | Signals serious defense preparation |
| Individual cancer claimants increasing | Adds mass tort weight to class action |
Watch for class certification rulings in mid-2026. That is the single most consequential legal event expected this year for this litigation.
Frequently Asked Questions
What is the Always pads lawsuit about in 2026?
The Always pads lawsuit in 2026 is a class action and mass tort case alleging that Procter and Gamble’s Always menstrual pads contain toxic chemicals including PFAS and dioxins.
Plaintiffs claim these chemicals were not disclosed and have caused serious health problems including cancer, hormonal disruption, and reproductive harm.
The case is currently in class certification proceedings with settlement negotiations also underway.
How much money can I get from the Always pads lawsuit settlement?
The settlement amount depends on the severity of your documented harm and which claimant tier you fall into.
Basic consumer claims may receive between $50 and $500, documented health conditions may qualify for $5,000 to $50,000, and cancer diagnoses could yield $50,000 or more.
Final amounts will be determined after the court approves a settlement and the total claims pool is calculated.
Who qualifies for the Always pads class action lawsuit?
Women who used Always branded menstrual pads in the United States from approximately 2015 through the present may qualify.
Qualification is strongest for women with medical documentation of related health conditions, but even women without diagnoses may claim economic harm as class members.
Product lines most frequently cited include Always Infinity, Always Radiant, and Always Ultra Thin.
What is the deadline to file an Always pads lawsuit claim in 2026?
No formal claims deadline has been announced yet for 2026 because the class has not received final court certification.
Once a settlement is announced and approved, a claims window will open, typically lasting 60 to 120 days.
Individual mass tort claimants should also check their state’s statute of limitations, which may run 2 to 4 years from discovery of harm.
What chemicals were found in Always pads that led to the lawsuit?
PFAS, also called forever chemicals, and dioxins are the primary substances at the center of the Always pads lawsuit.
Independent laboratory testing also flagged volatile organic compounds, pesticide residues, and synthetic fragrance chemicals as areas of concern.
These chemicals are linked to cancer, thyroid disease, reproductive harm, and immune system disruption in peer-reviewed scientific literature.
What You Should Do Before the Claims Window Closes
The Always pads lawsuit is real, it is moving fast in 2026, and the window to participate is still open. Women who act now, before a settlement is announced, will be better prepared than those who scramble at the last moment.
Start gathering documentation today. Pull together records of Always pad use, any relevant medical records, and save any product packaging you still have.
If you have a cancer diagnosis or serious health condition you believe may be connected to long-term menstrual pad use, speak with a plaintiff law firm now. Contingency-fee arrangements mean no upfront cost to you, and the consultation itself tells you where you stand.
